Chiba, Japan

Yoshimasa Kamikawaji

This inventor holds 9 USPTO granted patents. Top assignee: Nissan Chemical Industries Limited. Active years: 1989-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshimasa Kamikawaji. Retrieved from https://idiyas.com/inventor/yoshimasa-kamikawaji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.1

ph-index = 6

Forward Citations = 52(Granted Patents)


Location History:

  • Chiba-ken, JP (1998 - 1999)
  • Funabashi, JP (1989 - 2000)

Company Filing History:


Years Active: 1989-2000

Loading Chart...
9 patents (USPTO):Explore Patents

Title: **Yoshimasa Kamikawaji: Pioneering Innovations in Cardiac Medicines**

Introduction

Yoshimasa Kamikawaji is a notable inventor based in Chiba-ken, Japan, recognized for his contributions to the field of medicinal chemistry. With a robust portfolio of nine patents, Kamikawaji has made significant strides in the development of innovative pharmaceuticals.

Latest Patents

Among his latest remarkable inventions is a benzimidazole compound, which holds promise for treating cardiac insufficiency. This compound showcases his commitment to addressing critical health challenges through innovative solutions.

Career Highlights

Yoshimasa Kamikawaji is currently employed at Nissan Chemical Industries Limited, a company renowned for its advancements in chemical manufacturing and specialty products. His work at Nissan has allowed him to focus on research and development, leading to the successful patenting of new medical compounds that can enhance patient health.

Collaborations

Throughout his career, Kamikawaji has collaborated with esteemed colleagues, including Yukinori Masuda and Keizo Tanikawa. Their collective efforts in research further underscore the importance of teamwork in driving innovation and yielding significant advancements in medicine.

Conclusion

In conclusion, Yoshimasa Kamikawaji exemplifies the spirit of innovation within the pharmaceutical industry. His contributions, particularly in developing treatments for cardiac insufficiency through innovative compounds, highlight the positive impact of dedicated inventors on healthcare. Kamikawaji's ongoing work promises to lead to further breakthroughs, exemplifying the potential of research and collaboration in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…